{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:48:42Z","timestamp":1792414122378,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd013185","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000}}],"reference-count":124,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013185.pub2","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T11:41:46Z","timestamp":1780314106000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk prediction models for familial breast cancer"],"prefix":"10.1002","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4404-6564","authenticated-orcid":false,"given":"Sarah A","family":"McGarrigle","sequence":"additional","affiliation":[{"name":"Department of Surgery; Trinity College Dublin, Trinity St James's Cancer Institute; Dublin Ireland"},{"name":"Breast Care Department; St James's Hospital; Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne P","family":"Hanhauser","sequence":"additional","affiliation":[{"name":"Breast Care Department; St James's Hospital; Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mockler","sequence":"additional","affiliation":[{"name":"John Stearne Library; Trinity Centre for Health Sciences, St James's Hospital; Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Gallagher","sequence":"additional","affiliation":[{"name":"HOPE Directorate; St James's Hospital and Trinity College Dublin; Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Trinity St James's Cancer Institute; Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna AAG","family":"Damen","sequence":"additional","affiliation":[{"name":"Cochrane Netherlands; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University; Utrecht Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Bennett","sequence":"additional","affiliation":[{"name":"School of Population Health; RCSI University of Medicine and Health Sciences; Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M","family":"Connolly","sequence":"additional","affiliation":[{"name":"Department of Surgery; Trinity College Dublin, Trinity St James's Cancer Institute; Dublin Ireland"},{"name":"Breast Care Department; St James's Hospital; Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Supported by the Cochrane Breast Cancer Review Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD013185.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"303\u20134","DOI":"10.1093\/oxfordjournals.aje.a113306","article-title":"A shortcut method for calculating the 95 per cent confidence interval of the standardized mortality ratio","volume":"115","author":"Vandenbroucke","year":"1982","journal-title":"American Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD013185.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: a Cancer Journal for Clinicians"},{"issue":"17","key":"10.1002\/14651858.CD013185.pub2-BIB0003|cit3","first-page":"1651","article-title":"Breast-cancer risk in families with mutations in PALB2","volume":"371","author":"Antoniou","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013185.pub2-BIB0004|cit4","doi-asserted-by":"crossref","unstructured":"Easton DF Pharoah PD Antoniou AC Tischkowitz M Tavtigan SV Nathanson KL Gene-panel sequencing and the prediction of breast-cancer risk New England Journal of Medicine 2015 372 23 2243 57","DOI":"10.1056\/NEJMsr1501341"},{"issue":"11","key":"10.1002\/14651858.CD013185.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","article-title":"Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE","volume":"105","author":"Mavaddat","year":"2013","journal-title":"Journal of the National Cancer Institute"},{"issue":"2","key":"10.1002\/14651858.CD013185.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1399-0004.2012.01859.x","article-title":"Familial breast cancer","volume":"82","author":"Lalloo","year":"2013","journal-title":"Clinical Genetics"},{"issue":"4","key":"10.1002\/14651858.CD013185.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ng.2563","article-title":"Large-scale genotyping identifies 41 new loci associated with breast cancer risk","volume":"45","author":"Michailidou","year":"2013","journal-title":"Nature Genetics"},{"issue":"1","key":"10.1002\/14651858.CD013185.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2014.10.008","article-title":"Beyond BRCA: new hereditary breast cancer susceptibility genes","volume":"41","author":"Economopoulou","year":"2015","journal-title":"Cancer Treatment Reviews"},{"issue":"3","key":"10.1002\/14651858.CD013185.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0959-8049(96)00082-2","article-title":"Cancer genetics clinics","volume":"32A","author":"Evans","year":"1996","journal-title":"European Journal of Cancer"},{"issue":"21","key":"10.1002\/14651858.CD013185.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/jnci\/91.21.1829","article-title":"Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer","volume":"91","author":"Gail","year":"1999","journal-title":"Journal of the National Cancer Institute"},{"issue":"1","key":"10.1002\/14651858.CD013185.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1634\/theoncologist.7-1-60","article-title":"Breast cancer prevention","volume":"7","author":"Powles","year":"2002","journal-title":"Oncologist"},{"key":"10.1002\/14651858.CD013185.pub2-BIB0012|cit12","unstructured":"National Institute for Health and Care Excellence (NICE) Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer. Clinical guideline [CG164] NICE 2013"},{"key":"10.1002\/14651858.CD013185.pub2-BIB0013|cit13","doi-asserted-by":"crossref","unstructured":"Gadzicki D Evans DG Harris H Julian-Reynier C Nippert I Schmidtke J Genetic testing for familial\/hereditary breast cancer \u2013 comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany Journal of Community Genetics 2011 2 2 53 69","DOI":"10.1007\/s12687-011-0042-4"},{"issue":"10","key":"10.1002\/14651858.CD013185.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/jnci\/djq088","article-title":"Assessing women at high risk of breast cancer: a review of risk assessment models","volume":"102","author":"Amir","year":"2010","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD013185.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2288-14-3","article-title":"Developing and validating risk prediction models in an individual participant data meta-analysis","volume":"14","author":"Ahmed","year":"2014","journal-title":"BMC Medical Research Methodology"},{"issue":"2","key":"10.1002\/14651858.CD013185.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10549-011-1818-2","article-title":"A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance","volume":"132","author":"Meads","year":"2012","journal-title":"Breast Cancer Research and Treatment"},{"key":"10.1002\/14651858.CD013185.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"h3868","DOI":"10.1136\/bmj.h3868","article-title":"How to develop a more accurate risk prediction model when there are few events","volume":"351","author":"Pavlou","year":"2015","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD013185.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.2003.07.007","article-title":"Application of breast cancer risk prediction models in clinical practice","volume":"21","author":"Domchek","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD013185.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"b604","DOI":"10.1136\/bmj.b604","article-title":"Prognosis and prognostic research: developing a prognostic model","volume":"338","author":"Royston","year":"2009","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD013185.pub2-BIB0020|cit20","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-019-1158-4","article-title":"Machine learning techniques for personalized breast cancer risk prediction: comparison with the BCRAT and BOADICEA models","volume":"21","author":"Ming","year":"2019","journal-title":"Breast Cancer Research"},{"issue":"1","key":"10.1002\/14651858.CD013185.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1148\/radiol.2019182716","article-title":"A deep learning mammography-based model for improved breast cancer risk prediction","volume":"292","author":"Yala","year":"2019","journal-title":"Radiology"},{"issue":"10","key":"10.1002\/14651858.CD013185.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/L15-5093-2","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD)","volume":"162","author":"Collins","year":"2015","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD013185.pub2-BIB0023|cit23","first-page":"1","article-title":"Validation and updating of risk models based on multinomial logistic regression","volume":"1","author":"Van Calster","year":"2017","journal-title":"Diagnostic and Prognostic Research"},{"issue":"9","key":"10.1002\/14651858.CD013185.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1177\/0962280218785504","article-title":"A framework for meta-analysis of prediction model studies with binary and time-to-event outcomes","volume":"28","author":"Debray","year":"2019","journal-title":"Statistical Methods in Medical Research"},{"issue":"1","key":"10.1002\/14651858.CD013185.pub2-BIB0025|cit25","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-018-0947-5","article-title":"Assessment of performance of the Gail model for predicting breast cancer risk: a systematic review and meta-analysis with trial sequential analysis","volume":"20","author":"Wang","year":"2018","journal-title":"Breast Cancer Research"},{"issue":"1","key":"10.1002\/14651858.CD013185.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41416-019-0476-8","article-title":"A systematic review and quality assessment of individualised breast cancer risk prediction models","volume":"121","author":"Louro","year":"2019","journal-title":"British Journal of Cancer"},{"issue":"7","key":"10.1002\/14651858.CD013185.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"e055398","DOI":"10.1136\/bmjopen-2021-055398","article-title":"Risk prediction models for breast cancer: a systematic review","volume":"12","author":"Zheng","year":"2022","journal-title":"BMJ Open"},{"issue":"1","key":"10.1002\/14651858.CD013185.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-011-1853-z","article-title":"Risk prediction models of breast cancer: a systematic review of model performances","volume":"133","author":"Anothaisintawee","year":"2012","journal-title":"Breast Cancer Research and Treatment"},{"issue":"12","key":"10.1002\/14651858.CD013185.pub2-BIB0029|cit29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013185","article-title":"Risk prediction models for familial breast cancer","author":"McGarrigle","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD013185.pub2-BIB0030|cit30","first-page":"CD012022","article-title":"Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis","volume":"7","author":"Kreuzberger","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD013185.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"e1001744","DOI":"10.1371\/journal.pmed.1001744","article-title":"Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist","volume":"11","author":"Moons","year":"2014","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD013185.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"i6460","DOI":"10.1136\/bmj.i6460","article-title":"A guide to systematic review and meta-analysis of prediction model performance","volume":"356","author":"Debray","year":"2017","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD013185.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"e32844","DOI":"10.1371\/journal.pone.0032844","article-title":"Search filters for finding prognostic and diagnostic prediction studies in MEDLINE to enhance systematic reviews","volume":"7","author":"Geersing","year":"2012","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1002\/14651858.CD013185.pub2-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011318","article-title":"Prediction models for the risk of postoperative nausea and vomiting","author":"Pace","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"34","key":"10.1002\/14651858.CD013185.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1200\/JCO.21.01236","article-title":"A validated risk prediction model for breast cancer in US Black women","volume":"39","author":"Palmer","year":"2021","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD013185.pub2-BIB0036|cit36","unstructured":"Covidence Veritas Health Innovation 2025"},{"issue":"10","key":"10.1002\/14651858.CD013185.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD013185.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1001221","article-title":"Reporting and methods in clinical prediction research: a systematic review","volume":"9","author":"Bouwmeester","year":"2012","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD013185.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1741-7015-9-103","article-title":"Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting","volume":"9","author":"Collins","year":"2011","journal-title":"BMC Medicine"},{"key":"10.1002\/14651858.CD013185.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"i2416","DOI":"10.1136\/bmj.i2416","article-title":"Prediction models for cardiovascular disease risk in the general population: systematic review","volume":"353","author":"Damen","year":"2016","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013185.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1741-7015-8-20","article-title":"Reporting methods in studies developing prognostic models in cancer: a review","volume":"8","author":"Mallett","year":"2010","journal-title":"BMC Medicine"},{"key":"10.1002\/14651858.CD013185.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1741-7015-8-21","article-title":"Reporting performance of prognostic models in cancer: a review","volume":"8","author":"Mallett","year":"2010","journal-title":"BMC Medicine"},{"issue":"12","key":"10.1002\/14651858.CD013185.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S2213-2600(15)00428-2","article-title":"Childhood asthma prediction models: a systematic review","volume":"3","author":"Smit","year":"2015","journal-title":"Lancet. Respiratory Medicine"},{"issue":"5","key":"10.1002\/14651858.CD013185.pub2-BIB0044|cit44","first-page":"360","article-title":"Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review","volume":"98","author":"Van Dieren","year":"2012","journal-title":"Heart (British Cardiac Society)"},{"key":"10.1002\/14651858.CD013185.pub2-BIB0045|cit45","doi-asserted-by":"crossref","unstructured":"Van Doorn S Debray TP Kaasenbrood F Hoes AW Rutten FH Moons KG Predictive performance of the CHA2DS2-VASc rule in atrial fibrillation: a systematic review and meta-analysis Journal of Thrombosis and Haemostasis 2017 15 6 1065 77","DOI":"10.1111\/jth.13690"},{"key":"10.1002\/14651858.CD013185.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7326\/M18-1376","article-title":"PROBAST: a tool to assess the risk of bias and applicability of prediction model studies","volume":"170","author":"Wolff","year":"2019","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD013185.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M18-1377","article-title":"PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration","volume":"170","author":"Moons KG","year":"2019","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013185.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/ejcts\/ezr285","article-title":"Performance of the original EuroSCORE","volume":"41","author":"Siregar","year":"2012","journal-title":"European Journal of Cardio-thoracic Surgery"},{"issue":"19","key":"10.1002\/14651858.CD013185.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1002\/sim.4780141909","article-title":"Confidence interval estimates of an index of quality performance based on logistic regression models","volume":"14","author":"Hosmer","year":"1995","journal-title":"Statistics in Medicine"},{"issue":"11","key":"10.1002\/14651858.CD013185.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD013185.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M14-0698","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration","volume":"162","author":"Moons","year":"2015","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD013185.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12916-018-1099-2","article-title":"Poor reporting of multivariable prediction model studies: towards a targeted implementation strategy of the TRIPOD statement","volume":"16","author":"Heus","year":"2018","journal-title":"BMC Medicine"},{"issue":"7","key":"10.1002\/14651858.CD013185.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"e1001671","DOI":"10.1371\/journal.pmed.1001671","article-title":"Improving the transparency of prognosis research: the role of reporting, data sharing, registration, and protocols","volume":"11","author":"Peat","year":"2014","journal-title":"PLoS Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013185.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.3390\/cancers15041090","article-title":"Combining breast cancer risk prediction models","volume":"15","author":"Guan","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1002\/14651858.CD013185.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1214\/21-aoas1510","article-title":"Prediction of hereditary cancers using neural networks","volume":"16","author":"Guan","year":"2022","journal-title":"Annals of Applied Statistics"},{"key":"10.1002\/14651858.CD013185.pub2-BIB0056|cit56","unstructured":"R: A language and environment for statistical computing R Foundation for Statistical Computing 2025"},{"key":"10.1002\/14651858.CD013185.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/2046-4053-2-71","article-title":"Judging the quality of evidence in reviews of prognostic factor research: adapting the GRADE framework","volume":"2","author":"Huguet","year":"2013","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD013185.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jclinepi.2021.11.024","article-title":"GRADE concept paper 2: concepts for judging certainty on the calibration of prognostic models in a body of validation studies","volume":"143","author":"Foroutan","year":"2022","journal-title":"Journal of Clinical Epidemiology"},{"issue":"08","key":"10.1002\/14651858.CD013185.pub2-BIB0059|cit59","first-page":"7","article-title":"Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study. Chapter 2 Project 1: improvement of risk prediction algorithms for women at high risk of breast cancer Study 1a: cohort study","volume":"08","author":"Evans","year":"2016","journal-title":"NIHR Journals Library. Programme Grants for Applied Research"},{"key":"10.1002\/14651858.CD013185.pub2-BIB0060|cit60","first-page":"08","article-title":"Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study. Chapter 3 Project 2: assessment of predictive value of new genetic variants. Study 4: FH-Risk case-control","volume":"08","author":"Evans","year":"2016","journal-title":"NIHR Journals Library. Programme Grants for Applied Research"},{"issue":"24","key":"10.1002\/14651858.CD013185.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually","volume":"81","author":"Gail","year":"1989","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD013185.pub2-BIB0062|cit62","article-title":"NSABP breast cancer prevention trial risk assessment program, version 2","volume":"12","author":"Anderson","year":"1992","journal-title":"NSABP Biostatistical Center Technical Report"},{"issue":"18","key":"10.1002\/14651858.CD013185.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/jnci\/91.18.1541","article-title":"Validation studies for models projecting the risk of invasive and total breast cancer incidence","volume":"91","author":"Costantino","year":"1999","journal-title":"Journal of the National Cancer Institute"},{"issue":"2","key":"10.1002\/14651858.CD013185.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2217\/14796694.2.2.257","article-title":"Risk prediction models for familial breast cancer","volume":"2","author":"Antoniou","year":"2006","journal-title":"Future Oncology (London, England)"},{"issue":"11","key":"10.1002\/14651858.CD013185.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/jmg.40.11.807","article-title":"Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme","volume":"40","author":"Amir","year":"2003","journal-title":"Journal of Medical Genetics"},{"issue":"8","key":"10.1002\/14651858.CD013185.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/jnci\/86.8.620","article-title":"Validation of a breast cancer risk assessment model in women with a positive family history","volume":"86","author":"Bondy","year":"1994","journal-title":"Journal of the National Cancer Institute"},{"issue":"1","key":"10.1002\/14651858.CD013185.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13058-019-1126-z","article-title":"Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model","volume":"21","author":"Clendenen","year":"2019","journal-title":"Breast Cancer Research"},{"issue":"7","key":"10.1002\/14651858.CD013185.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1158\/1055-9965.EPI-18-1039","article-title":"Comparison of questionnaire-based breast cancer prediction models in the Nurses' Health Study","volume":"28","author":"Glynn","year":"2019","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"18","key":"10.1002\/14651858.CD013185.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1002\/sim.6176","article-title":"Assessing the goodness of fit of personal risk models","volume":"33","author":"Gong","year":"2014","journal-title":"Statistics in Medicine"},{"issue":"9","key":"10.1002\/14651858.CD013185.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.3390\/cancers15092559","article-title":"Will absolute risk estimation for time to next screen work for an Asian mammography screening population?","volume":"15","author":"Ho","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1002\/14651858.CD013185.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"e223077","DOI":"10.1148\/radiol.223077","article-title":"Comparison of the diagnostic accuracy of mammogram-based deep learning and traditional breast cancer risk models in patients who underwent supplemental screening with MRI","volume":"308","author":"Lamb","year":"2023","journal-title":"Radiology"},{"issue":"20","key":"10.1002\/14651858.CD013185.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/cancers13205194","article-title":"Prospective evaluation over 15 years of six breast cancer risk models","volume":"13","author":"Li","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1002\/14651858.CD013185.pub2-BIB0073|cit73","first-page":"37","article-title":"Evaluation of models for the prediction of breast cancer development in women at high risk","volume":"1","author":"Mayo","year":"2001","journal-title":"Journal of Applied Research"},{"issue":"5","key":"10.1002\/14651858.CD013185.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jnci\/djz177","article-title":"Performance of breast cancer risk-assessment models in a large mammography cohort","volume":"112","author":"McCarthy","year":"2020","journal-title":"Journal of the National Cancer Institute"},{"issue":"1","key":"10.1002\/14651858.CD013185.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/cancers14010045","article-title":"Validation of breast cancer risk models by race\/ethnicity, family history and molecular subtypes","volume":"14","author":"McCarthy","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1002\/14651858.CD013185.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13058-019-1158-4","article-title":"Machine learning techniques for personalized breast cancer risk prediction: comparison with the BCRAT and BOADICEA models","volume":"21","author":"Ming","year":"2019","journal-title":"Breast Cancer Research"},{"issue":"6","key":"10.1002\/14651858.CD013185.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"R144","DOI":"10.1186\/bcr3352","article-title":"Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance","volume":"14","author":"Quante","year":"2012","journal-title":"Breast Cancer Research"},{"issue":"11","key":"10.1002\/14651858.CD013185.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"Abstract PR","DOI":"10.1158\/1940-6207.PREV-12-PR-02","article-title":"Breast cancer risk assessment: genetic and non-genetic risk factors contributing to differential model performance","volume":"5","author":"Quante","year":"2012","journal-title":"Cancer Prevention Research (Philadelphia, Pa)"},{"issue":"5","key":"10.1002\/14651858.CD013185.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/jnci\/93.5.358","article-title":"Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention","volume":"93","author":"Rockhill","year":"2001","journal-title":"Journal of the National Cancer Institute"},{"issue":"1","key":"10.1002\/14651858.CD013185.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4274\/ejbh.galenos.2021.2021-8-2","article-title":"The value of Tyrer-Cuzick versus Gail risk modeling in predicting benefit from screening MRI in breast cancer","volume":"18","author":"Sevdalis","year":"2022","journal-title":"European Journal of Breast Health"},{"issue":"4","key":"10.1002\/14651858.CD013185.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S1470-2045(18)30902-1","article-title":"10-year performance of four models of breast cancer risk: a validation study","volume":"20","author":"Terry","year":"2019","journal-title":"Lancet Oncology"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD013185.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"Abstract PR07","DOI":"10.1158\/1538-7755.CARISK16-PR07","article-title":"Comparison of risk model recommendations for women at high-risk of breast cancer based on clinical thresholds using the Prospective Family Study Cohort (ProF-SC)","volume":"26","author":"Terry","year":"2017","journal-title":"Cancer Epidemiology Biomarkers and Prevention"},{"issue":"7","key":"10.1002\/14651858.CD013185.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer","year":"2004","journal-title":"Statistics in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD013185.pub2-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/sim.1913","article-title":"A breast cancer prediction model incorporating familial and personal risk factors (vol 23, pg 1111, 2004)","volume":"24","author":"Tyrer","year":"2005","journal-title":"Statistics in Medicine"},{"issue":"12","key":"10.1002\/14651858.CD013185.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/aje\/152.12.1154","article-title":"Familial breast and ovarian cancer: a Swedish population-based register study","volume":"152","author":"Anderson","year":"2000","journal-title":"American Journal of Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD013185.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/bcr1750","article-title":"Breast cancer risk-assessment models","volume":"9","author":"Evans","year":"2007","journal-title":"Breast Cancer Research"},{"issue":"6","key":"10.1002\/14651858.CD013185.pub2-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"100820","DOI":"10.1016\/j.gim.2023.100820","article-title":"Validation of the International Breast Cancer Intervention Study (IBIS) model in the high risk Ontario breast screening program: a retrospective cohort study","volume":"25","author":"Brooks","year":"2023","journal-title":"Genetics in Medicine"},{"issue":"12","key":"10.1002\/14651858.CD013185.pub2-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.3390\/cancers15123246","article-title":"A clinical risk model for personalized screening and prevention of breast cancer","volume":"15","author":"Eriksson","year":"2023","journal-title":"Cancers"},{"issue":"14","key":"10.1002\/14651858.CD013185.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1200\/JCO.22.01564","article-title":"Long-term performance of an image-based short-term risk model for breast cancer","volume":"41","author":"Eriksson","year":"2023","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD013185.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1200\/PO.20.00246","article-title":"Integrating clinical and polygenic factors to predict breast cancer risk in women undergoing genetic testing","volume":"5","author":"Hughes","year":"2021","journal-title":"JCO Precision Oncology"},{"issue":"8","key":"10.1002\/14651858.CD013185.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.21873\/anticanres.12760","article-title":"Accuracy of risk prediction models for breast cancer and BRCA1\/BRCA2 mutation carrier probabilities in Israel","volume":"38","author":"Kenan","year":"2018","journal-title":"Anticancer Research"},{"issue":"6","key":"10.1002\/14651858.CD013185.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1017\/S0016672313000232","article-title":"Breast cancer risk prediction accuracy in Jewish Israeli high-risk women using the BOADICEA and IBIS risk models","volume":"95","author":"Laitman","year":"2013","journal-title":"Genetics Research"},{"issue":"3","key":"10.1002\/14651858.CD013185.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"pkab021","DOI":"10.1093\/jncics\/pkab021","article-title":"Prospective evaluation of the addition of polygenic risk scores to breast cancer risk models","volume":"5","author":"Li","year":"2021","journal-title":"JNCI Cancer Spectrum"},{"issue":"7","key":"10.1002\/14651858.CD013185.pub2-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"101128","DOI":"10.1016\/j.gim.2024.101128","article-title":"Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factors","volume":"26","author":"Mabey","year":"2024","journal-title":"Genetics in Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013185.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/jnci\/djz194","article-title":"Considerations when using breast cancer risk models for women with negative BRCA1\/BRCA2 mutation results","volume":"112","author":"MacInnis","year":"2020","journal-title":"Journal of the National Cancer Institute"},{"issue":"7","key":"10.1002\/14651858.CD013185.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djv124","article-title":"Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk","volume":"107","author":"Quante","year":"2015","journal-title":"Journal of the National Cancer Institute"},{"issue":"5","key":"10.1002\/14651858.CD013185.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1186\/s13058-014-0451-5","article-title":"Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I","volume":"16","author":"Warwick","year":"2014","journal-title":"Breast Cancer Research"},{"issue":"1","key":"10.1002\/14651858.CD013185.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/sj.bjc.6600008","article-title":"A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes","volume":"86","author":"Antoniou","year":"2002","journal-title":"British Journal of Cancer"},{"issue":"8","key":"10.1002\/14651858.CD013185.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/sj.bjc.6602175","article-title":"The BOADICEA model of genetic susceptibility to breast and ovarian cancer","volume":"91","author":"Antoniou","year":"2004","journal-title":"British Journal of Cancer"},{"issue":"8","key":"10.1002\/14651858.CD013185.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/sj.bjc.6604305","article-title":"The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions","volume":"98","author":"Antoniou","year":"2008","journal-title":"British Journal of Cancer"},{"issue":"2","key":"10.1002\/14651858.CD013185.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/bjc.2013.730","article-title":"BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface","volume":"110","author":"Lee","year":"2014","journal-title":"British Journal of Cancer"},{"issue":"12","key":"10.1002\/14651858.CD013185.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/gim.2016.31","article-title":"Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model","volume":"18","author":"Lee","year":"2016","journal-title":"Genetics in Medicine"},{"issue":"8","key":"10.1002\/14651858.CD013185.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/s41436-018-0406-9","article-title":"BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors","volume":"21","author":"Lee","year":"2019","journal-title":"Genetics in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD013185.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gepi.1014","article-title":"Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study","volume":"21","author":"Antoniou","year":"2001","journal-title":"Genetic Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD013185.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/gim.2016.43","article-title":"Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab","volume":"19","author":"Li","year":"2017","journal-title":"Genetics in Medicine"},{"issue":"5","key":"10.1002\/14651858.CD013185.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/s41416-020-0937-0","article-title":"Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendations","volume":"123","author":"Ming","year":"2020","journal-title":"British Journal of Cancer"},{"issue":"1","key":"10.1002\/14651858.CD013185.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10689-011-9495-1","article-title":"Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer","volume":"11","author":"Stahlbom","year":"2012","journal-title":"Familial Cancer"},{"issue":"11","key":"10.1002\/14651858.CD013185.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1200\/JCO.2002.05.121","article-title":"BRCAPRO validation, sensitivity of genetic testing of BRCA1\/BRCA2, and prevalence of other breast cancer susceptibility genes","volume":"20","author":"Berry","year":"2002","journal-title":"Journal of Clinical Oncology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD013185.pub2-BIB0109|cit109","first-page":"147","article-title":"Recent enhancements to the genetic risk prediction model BRCAPRO","volume":"14","author":"Mazzola","year":"2015","journal-title":"Cancer Informatics"},{"issue":"1","key":"10.1002\/14651858.CD013185.pub2-BIB0110|cit110","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1086\/301670","article-title":"Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2","volume":"62","author":"Parmigiani","year":"1998","journal-title":"American Journal of Human Genetics"},{"issue":"5","key":"10.1002\/14651858.CD013185.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/jnci\/djt008","article-title":"Validation of a breast cancer risk prediction model developed for Black women","volume":"105","author":"Boggs","year":"2013","journal-title":"Journal of the National Cancer Institute"},{"issue":"2","key":"10.1002\/14651858.CD013185.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10689-013-9694-z","article-title":"Breast cancer risk assessment in 8,824 women attending a family history evaluation and screening programme","volume":"13","author":"Evans","year":"2014","journal-title":"Familial Cancer"},{"issue":"7","key":"10.1002\/14651858.CD013185.pub2-BIB0113|cit113","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1200\/JCO.22.02470","article-title":"Extending the Breast Cancer Surveillance Consortium model of invasive breast cancer","volume":"42","author":"Gard","year":"2024","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD013185.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"e0248930","DOI":"10.1371\/journal.pone.0248930","article-title":"Developing and validating an individualized breast cancer risk prediction model for women attending breast cancer screening","volume":"16","author":"Louro","year":"2021","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1002\/14651858.CD013185.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13058-019-1158-4","article-title":"Machine learning techniques for personalized breast cancer risk prediction: comparison with the BCRAT and BOADICEA models","volume":"21","author":"Ming","year":"2019","journal-title":"Breast Cancer Research"},{"key":"10.1002\/14651858.CD013185.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"b606","DOI":"10.1136\/bmj.b606","article-title":"Prognosis and prognostic research: application and impact of prognostic models in clinical practice","volume":"338","author":"Moons","year":"2009","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD013185.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"e1001381","DOI":"10.1371\/journal.pmed.1001381","article-title":"Prognosis Research Strategy (PROGRESS) 3: prognostic model research","volume":"10","author":"Steyerberg","year":"2013","journal-title":"PLoS Medicine"},{"issue":"6","key":"10.1002\/14651858.CD013185.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/jnci\/djaa178","article-title":"Comparing 5-year and lifetime risks of breast cancer using the prospective family study cohort","volume":"113","author":"MacInnis","year":"2021","journal-title":"Journal of the National Cancer Institute"},{"issue":"5","key":"10.1002\/14651858.CD013185.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/bjc.2013.382","article-title":"Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre","volume":"109","author":"MacInnis","year":"2013","journal-title":"British Journal of Cancer"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD013185.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"A66","DOI":"10.1186\/1897-4287-10-S2-A66","article-title":"Validation study of risk prediction models for female relatives of Australian women with breast cancer","volume":"10","author":"MacInnis","year":"2012","journal-title":"Hereditary Cancer in Clinical Practice"},{"key":"10.1002\/14651858.CD013185.pub2-BIB0121|cit121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-023-11174-w","article-title":"Understanding the contribution of lifestyle in breast cancer risk prediction: a systematic review of models applicable to Europe","volume":"687","year":"2023","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1002\/14651858.CD013185.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3390\/cancers15041124","article-title":"Breast cancer risk assessment tools for stratifying women into risk groups: a systematic review","volume":"15","author":"Velentzis","year":"2023","journal-title":"Cancers"},{"issue":"8","key":"10.1002\/14651858.CD013185.pub2-BIB0123|cit123","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1136\/jmg-2024-109943","article-title":"Validation of the BOADICEA model in a prospective cohort of <ovid:i>BRCA1\/2<\/ovid:i> pathogenic variant carriers","volume":"61","author":"Yang","year":"2024","journal-title":"Journal of Medical Genetics"},{"issue":"e078378","key":"10.1002\/14651858.CD013185.pub2-BIB0124|cit124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:34:02Z","timestamp":1792413242000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013185.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":124,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013185.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}